Zimmer Biomet Announces Fourth Quarter and Full-Year 2019 Financial Results

Go back to Zimmer Biomet Announces Fourth Quarter and Full-Year 2019 Financial Results

Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 3c, Revenues Beat; Offers FY20 EPS Guidance

February 4, 2020 6:02 AM EST

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.30, $0.03 better than the analyst estimate of $2.27. Revenue for the quarter came in at $2.13 billion versus the consensus estimate of $2.11 billion.

"In 2019 we continued to successfully execute our plan to reposition the company... More